Bsfllp Description


Print this page

Legal Battle Over Tracking Stocks Heats Up

The Boston Globe, August 11, 2003

Reporting that BSF had filed Amended Complaint asserting class action claims against Genzyme Corporation over the elimination of one of its publicly-traded "tracking stocks." Plaintiffs seek damages as a result of alleged market manipulation by Genzyme intended to buy out the equity of certin minority shareholders at massive discount off of fair market value.

Related Lawyer: Jonathan Sherman

Related Practices: Class Actions, Securities Litigation